Pages
Products
Human KLF5 adenoviral particles

Human KLF5 adenoviral particles

Cat.No. :  AD00196Z

Titer: ≥1x10^10 IFU/mL / ≥1x10^11 IFU/mL / ≥1x10^11 VP/mL / ≥1x10^12 VP/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Adenovirus Particle Information

Quality Control

Cat. No. AD00196Z
Target Gene KLF5
Species Human
Product Type Adenoviral particle
Insert KLF5
Titer Varies lot by lot, for example, ≥1x10^10 IFU/mL, ≥1x10^11 IFU/mL, ≥1x10^11 VP/mL etc.
Size Varies lot by lot, for example, 250 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality adenovirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between adenovirus particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in adenovirus production, especially for applications in animal studies and gene therapy. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced adenovirus particles to ensure regulatory compliance.
Sterility Creative Biogene ensures that adenovirus products are free of any bacterial, fungal and other microbial contamination.
Ad5 E1 Detection All Creative Biogene adenoviruses are PCR tested to ensure that there are no detectable E1 sequences in the particles, which could be from revertants or external E1 contamination.
RCA Assays Adenovirus products originating at Creative Biogene are guaranteed to have undetectable replication-competent adenovirus (RCA). This quality control measure is important because there is always the possibility of wild-type contamination due to revertants or environmental sources.
PFU Titering All purified adenovirus preparations are tested for infectious titer. Creative Biogene's PFU test takes a few days longer but counts true plaques in HEK cells rather than estimating PFU titers via IHC staining or TCI50 of infected cells.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Krüppel-like factor 5 (KLF5) is a member of the Krüppel-like transcription factor family and plays a key role in cell proliferation, differentiation, apoptosis, and embryonic development. KLF5 is widely expressed in various tissues, including the cardiovascular system, gastrointestinal tract, and skin, and regulates key signaling pathways such as Wnt/β-catenin, TGF-β, and MAPK. Studies have shown that KLF5 is involved in both physiological processes (such as tissue repair) and pathological states (such as cancer and cardiovascular disease). It has dual roles as an oncogene and tumor suppressor gene depending on the cellular context, making it a key target for biomedical research. KLF5 regulates gene expression by binding to GC-rich promoter regions, thereby affecting cell cycle progression, angiogenesis, and epithelial-mesenchymal transition (EMT). Given its regulatory versatility, KLF5 has become a promising candidate gene for gene therapy and mechanistic studies.

Human KLF5 adenoviral particles are recombinant viral vectors designed to efficiently deliver the KLF5 gene to target cells. This adenoviral vector system ensures stable transient overexpression of KLF5, making it ideal for functional studies, such as investigating the role of KLF5 in cellular processes or disease models. These particles are typically replication-defective, ensuring biosafety while maintaining high gene delivery capacity. Researchers have used KLF5 adenoviral particles to explore mechanisms of cancer biology, cardiovascular remodeling, stem cell differentiation, and tissue regeneration. In addition, they are valuable tools for drug screening and therapeutic development, allowing precise manipulation of KLF5 expression in vitro and in vivo.

Although the transcription factor Krüppel-like factor 5 (KLF5) plays an important role in both inflammation and cancer, the mechanism by which this factor promotes cervical carcinogenesis remains unclear. Here, researchers demonstrate a potential role for tumor necrosis factor receptor superfamily member 11a (TNFRSF11a), whose corresponding gene is a direct binding target of KLF5, in tumor cell proliferation and invasiveness. Co-expression of KLF5 and TNFRSF11a significantly correlated with tumorigenesis in cervical tissues, and manipulation of KLF5 expression had a positive effect on TNFRSF11a mRNA and protein expression. Functionally, KLF5 promoted cancer cell proliferation, migration, and invasiveness in a manner that was partially dependent on TNFRSF11a expression. Furthermore, in vivo studies in functional TNFRSF11a knockdown mice showed suppressed tumorigenicity and liver metastatic potential. Notably, tumor necrosis factor (TNF)-α induces KLF5 expression by activating the p38 signaling pathway, and high KLF5 and TNFRSF11a expression increases the risk of death in patients with cervical squamous cell carcinoma. These findings suggest that KLF5 and TNFRSF11a promote cervical cancer cell proliferation, migration, and invasion.

KLF5 has been reported to exert pro-oncogenic activity by regulating gene transcription and stimulating cancer cell progression. TNF-α is an indispensable cytokine that modulates the local microenvironment, thereby promoting CC progression. To further investigate whether KLF5 is an effector of TNFRSF11a and whether KLF5 plays a role in TNF-α-induced CC cell functions, the researchers overexpressed KLF5 in HeLa cells by infection with a specific adenovirus (Ad-KLF5). As shown in Figures 1a and b, KLF5 overexpression led to a sustained upregulation of TNFRSF11a protein and mRNA in HeLa cells. HeLa cell proliferation was further tested using the CCK-8 assay, and migration and invasion were tested using the Transwell assay. The results showed that TNF-α significantly induced HeLa cell proliferation (Figure 1c). Furthermore, treatment with TNF-α and/or Ad-KLF5 resulted in increased migration and invasion in Transwell assays compared with HeLa cells expressing green fluorescent protein (Ad-GFP) alone, indicating increased metastatic potential (Figure 1d, e). These results suggest that KLF5 affects TNFRSF11a expression, thereby promoting TNF-α-induced CC cell migration and invasion.

KLF5 mediates tumour necrosis factor (TNF)-a-induced cervical cancer cell migration and invasion.Figure 1. KLF5 mediates tumour necrosis factor (TNF)-α-induced cervical cancer cell migration and invasion. (Ma D, et al., 2017)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Work well

Used in cancer proliferation assays—the particles worked flawlessly on first try. Saved weeks of troubleshooting compared to other vendors.

French

03/15/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction